These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 25194884

  • 1. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Kirsten AM, Watz H, Brindicci C, Piccinno A, Magnussen H.
    Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of beclometasone dipropionate/formoterol extra-fine fixed combination on the peripheral airway inflammation in controlled asthma.
    Bulac S, Cimrin A, Ellidokuz H.
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):82-7. PubMed ID: 25050594
    [Abstract] [Full Text] [Related]

  • 7. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
    Crisafulli E, Zanini A, Pisi G, Pignatti P, Poli G, Scuri M, Chetta A.
    Expert Rev Respir Med; 2016 Apr; 10(5):481-90. PubMed ID: 26938578
    [Abstract] [Full Text] [Related]

  • 8. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF.
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S, Terada M, Hozawa M.
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
    Corda L, Gardenghi GG, Modina D, Montemurro LT, Novali M, Tantucci C.
    Allergy Asthma Proc; 2011 Apr; 32(6):29-34. PubMed ID: 22221427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA, Petrova D, Kralimarkova TZ, Ivanov Y, Popova T, Peneva M, Odzhakova T, Ilieva Y, Yakovliev P, Lazarova T, Georgiev O, Hodzhev V, Hodzheva E, Staevska MT, Dimitrov VD.
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Murphy KR, Dhand R, Trudo F, Uryniak T, Aggarwal A, Eckerwall G.
    Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Mukhopadhyay A, Waked M, Gogtay J, Gaur V.
    Respir Med; 2020 Feb; 170():106055. PubMed ID: 32843176
    [Abstract] [Full Text] [Related]

  • 19. Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.
    Carpagnano GE, Scioscia G, Lacedonia D, Stornelli SR, Irene Quarato CM, Soccio P, Resta O, Foschino Barbaro MP.
    Pulm Pharmacol Ther; 2020 Feb; 60():101879. PubMed ID: 31866498
    [Abstract] [Full Text] [Related]

  • 20. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care.
    Price DB, Carter V, Martin J, Gardener EA, Skinner D, Yang S, Hoffman M, Willis JC, Cooper AJ.
    Drugs; 2020 Jan; 80(1):47-60. PubMed ID: 31749061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.